The MAPK/ERK signaling pathway is another crucial target for inhibitors. Inhibitors targeting MAPK/ERK are employed in cancer treatments to protect against unchecked cell expansion and tumor growth.Antibiotics are a part of inhibitors that have changed the administration of bacterial infections. By targeting bacterial cell wall surfaces, protein sy